Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Pediatr Blood Cancer. 2019 Mar 22;66(6):e27721. doi: 10.1002/pbc.27721

Table 1.

Multivariable model predicting receipt of at least 300 days of hydroxyurea among children with SCA with evidence of hydroxyurea use (N=4370 person-years).

Predictor Odds Ratio 95% Confidence Interval P-Value

Inpatient Visits 0.77 0.73, 0.81 <0.0001
ED Visits 1.01 0.99, 1.04 0.1982
Outpatient Visits 1.01 1.00, 1.02 0.0018
Age 0.93 0.91, 0.94 <0.0001
Sex
  Male Reference Reference Reference
  Female 0.92 0.78, 1.08 0.2803
State
  Illinois Reference Reference Reference
  Michigan 1.12 0.83, 1.50 0.4635
  Louisiana 0.93 0.71, 1.24 0.6339
  South Carolina 0.55 0.39, 0.79 0.0010
  Texas 0.78 0.59, 1.03 0.0754
  Florida 0.96 0.74, 1.24 0.7567
Year
  2005 Reference Reference Reference
  2006 0.85 0.59, 1.22 0.3861
  2007 0.90 0.63, 1.29 0.5669
  2008 0.93 0.65, 1.32 0.6683
  2009 0.67 0.47, 0.97 0.0311
  2010 0.80 0.57, 1.12 0.1944
  2011 0.69 0.49, 0.96 0.0273
  2012 0.64 0.46, 0.89 0.0076